← Back to Search

Behavioral Intervention

Time Restricted Eating During Chemotherapy for Breast Cancer

N/A
Recruiting
Led By Kelsey Gabel, MS, RD, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Demonstrates adequate organ function (absolutely neutrophil count ≥ 1,500/μL)
Breast cancer to meet histologically confirmed Stage I-III
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trialwill study if time-restricted eating can help improve cancer treatment and reduce side effects. #BreastCancer

Who is the study for?
This trial is for women aged 25-99 with Stage I-III breast cancer, who are not pregnant or breastfeeding, do not have severe heart conditions, hepatitis, diabetes, eating disorders, a BMI outside of 25-40kg/m2 range or other major health issues. Participants must be able to follow the study procedures and provide consent.Check my eligibility
What is being tested?
The study tests if time restricted eating (TRE), alone or combined with a Mediterranean diet (MedTRE), can improve outcomes of chemotherapy for breast cancer patients. It aims to see if these diets limit weight gain and enhance cardiometabolic health during treatment.See study design
What are the potential side effects?
While specific side effects are not listed for TRE and MedTRE interventions in this context, potential risks may include hunger pangs, fatigue due to calorie restriction, nutritional deficiencies if improperly followed, and psychological stress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My blood tests show my organs are working well.
Select...
My breast cancer is confirmed to be at Stage I, II, or III.
Select...
I am between 25 and 99 years old.
Select...
I am fully active or can carry out light work.
Select...
I understand and can follow the study's procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility 8-h TRE
Secondary outcome measures
Body composition
Body weight change
Change in glucose
+4 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Time restricted eatingExperimental Treatment1 Intervention
Participants will eat all food within the same self selected 8 hour window daily.
Group II: Med TREExperimental Treatment1 Intervention
Participants will eat a mediterranean style diet within the same self selected 8 hour window daily.
Group III: Standard careActive Control1 Intervention
Current standard care is to eat enough calories and protein to maintain weight and lean mass.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
604 Previous Clinical Trials
1,558,955 Total Patients Enrolled
11 Trials studying Breast Cancer
1,342,356 Patients Enrolled for Breast Cancer
Kelsey Gabel, MS, RD, PhDPrincipal InvestigatorUIC

Media Library

8-h time restricted eating (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05259410 — N/A
Breast Cancer Research Study Groups: Time restricted eating, Med TRE, Standard care
Breast Cancer Clinical Trial 2023: 8-h time restricted eating Highlights & Side Effects. Trial Name: NCT05259410 — N/A
8-h time restricted eating (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05259410 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any slots available for potential participants in this experiment?

"Affirmative. Per the information listed on clinicaltrials.gov, this trial is presently recruiting participants. It was first revealed on August 1st 2022 and updated lastly November 30th 2022; 40 individuals will be welcomed from a single location."

Answered by AI

Do I have the required qualifications to participate in this medical research?

"This clinical trial is currently seeking 40 individuals aged between 25 and 99 that have been diagnosed with a neoplasm. The eligibility requirements are as follows: Aged 25-99 at time of consent, ECOG 0 or 1, Breast cancer to meet histologically confirmed Stage I-III., Adequate organ function (absolutely neutrophil count ≥ 1,500/μL)., All screening labs must be taken within 30 days prior to registration., Ability to comprehend and adhere to protocol requirements for the entirety of the study period., Provide written informed consent and HIPAA authorization for release of personal health information via an approved UIC Institutional"

Answered by AI

What is the maximum capacity of enrollees for this research?

"Affirmative. According to the information on clinicaltrials.gov, this medical trial is presently in its recruitment phase which began August 1st 2022 and was last updated November 30th 2022. A total of 40 patients are needed from one specific centre for participation."

Answered by AI

Is the enrollment criterion for this investigation restricted to people below a certain age?

"This medical study is searching for individuals aged 25 and above, but under 99 years old."

Answered by AI
~14 spots leftby Mar 2025